Company: HRTX
Filing Date: 2025-08-15
Form Type: 8-K
Source: 0000950170-25-109234
Chunk: 9

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-08-15
Form: 8-K
Item: Item 9.01
Chunk 9
---
Item 9.01 Financial Statements and Exhibits.

  Exhibit No.      Description                                                                                                                                                                                           
          3.1      Certificate of Designation of Series B Preferred Stock filed with the Secretary of State of the State of Delaware on August 14, 2025                                                                  
          4.1      Tax Benefit Preservation Plan between Heron Therapeutics, Inc. and Computershare Trust Company N. A. dated August 14, 2025, which includes the Form of Certificate of Designations of Series B Pr...  
         99.1      Press Release, dated August 15, 2025                                                                                                                                                                  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document).                                                                                                                          

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                             Heron Therapeutics, Inc.                           
  Date: August 15, 2025      /s/ Ira Duarte                                     
                             Ira Duarte